Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.65
-1.69 (-5.96%)
At close: Oct 13, 2026, 4:00 PM EDT
26.67
+0.02 (0.08%)
After-hours: Oct 13, 2026, 7:57 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.11 billion as of October 13, 2026. It is the 4,863rd most valuable company in the world and the 1,431st biggest in the United States. Its market cap has decreased by 17.62% in one year.
Market Cap
3.11B
Enterprise Value
2.61B
1-Year Change
-17.62%
Global Rank
Country Rank
#1,431 United States
Category
ChartMarket Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.11B, an increase of 3,911.36%. That is a compound annual growth rate of 37.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 3.11B | -21.82% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 3.61B |
| Xenon Pharmaceuticals | 3.53B |
| IDEAYA Biosciences | 3.48B |
| Acadia Pharmaceuticals | 3.41B |
| Parabilis Medicines | 3.39B |
| Arcutis Biotherapeutics | 3.34B |
| Celcuity | 3.32B |
| Tarsus Pharmaceuticals | 3.21B |